Back to Journals » OncoTargets and Therapy » Volume 19
Next-Generation Sequence Detects ARAP3 as a Novel Oncogene in Papillary Thyroid Carcinoma [Retraction]
This retraction applies to:
published online on 18/11/2016Wang QX, Chen ED, Cai YF, et al. Onco Targets Ther. 2016;9:7161–7167. https://doi.org/10.2147/OTT.S115668
We, the Editors and Publisher of the journal OncoTargets and Therapy, have retracted the published article.
After publication, concerns have been raised by a third party in 2023 about the integrity of the data in Figure 4 of the article.
Further investigation conducted by the Journal and Publisher confirmed duplicate image panels representative of different treatment conditions present in Figure 4.
When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher.
As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
This retraction relates to this paper
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.